|
|
|
|
Shifting the Neoantigen Vaccine Development Paradigm
NGS best practices for neoantigen identification & clinical trial implementation
Date: Tuesday, November 15, 2016
Time: 1pm EST (10am PST)
Advances in immuno-oncology research have revealed the exciting
potential of the new class of immunogenic targets, neoantigens, in
the development of personalized cancer vaccines. However, because
neoantigen sets are uniquely specific to each patient, the development
of these personalized vaccines has, to date, proven difficult in terms
of achieving accurate candidate neoantigen identification, therapeutic
production, and perhaps most significantly, clinical trial
implementation.
In this webinar, learn to overcome these challenges by:
- Optimizing FFPE sample preparation for DNA and RNA sequencing,
- Achieving comprehensive candidate neoantigen identification with augmented whole exome and whole transcriptome sequencing,
- Validating your bioinformatics pipeline for neoantigen prediction, and
- Designing rapid, patient-centric processes for vaccine clinical trials.
 |
|
Speakers:
 |
Erin Newburn, MS, PhD
Manager, Field Applications Scientist
Personalis, Inc.
For more information,
contact us at [email protected]. |
|
Speakers:
 |
Christelle Johnson, MS, PhD
Field Applications Scientist
Personalis, Inc.
|
|
|
|
|
|
Shifting the Neoantigen Vaccine Development Paradigm
